Thyrocare Technologies Limited

Web: thyrocare.com NSE: THYROCARE BSE: 539871 SECTOR: Healthcare - Healthcare Services | Add Note | View Notes

578 1(0%)

Volume

9L as on 23, Jun

Open

941

High

954

Low

941

579

VWAP

556

52 Week High

662

52 Week Low

343

Viand Research Rating

Quality Score

80/100

Growth Score

71/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

9,197

No. of Shares

15.9

P/E

58.08

P/B

10.77

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

18.54

ROCE

Profit Growth

Listing Date

09-May-16

Promoter Holding

60.92%

FII Holding

5.37%

DII Holding

21%

Price Chart

Price Performance

1 Week5%

1 Month20%

3 Months50%

6 Months49%

1 Year49%

YTD49%

Moving Average

5 Day SMA542

10 Day SMA536

20 Day SMA529

30 Day SMA510

50 Day SMA472

61 Day SMA454

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	558	547	553	552
Resistance 2	553	546	550	550
Resistance 1	549	546	548	543
Pivot Point	545	545	545	542
Support 1	541	544	542	535
Support 2	536	543	540	533
Support 3	532	542	536	526

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 60.92%	(-10.11) 60.93%	(0.01) 71.06%	(0.01) 71.06%	(0.01) 71.06%	(0.01) 71.06%	(0.01) 71.11%	(0.01) 71.11%	(0.01) 71.11%	(0.01) 71.11%	(0.01) 71.14%	(0.01) 71.14%	(0.01) 71.14%	(0.01) 71.14%	(0.01) 71.14%	(0.01) 71.18%	(0.01) 71.18%	(0.01) 71.18%	(0.01) 71.22%
FIIs	(0.41) 5.37%	(0.11) 4.96%	(1.61) 4.85%	(0.81) 3.23%	(-0.41) 2.41%	(0.81) 2.77%	(-0.61) 1.93%	(-0.41) 2.49%	(-0.51) 2.90%	(-0.11) 3.35%	(0.01) 3.46%	(-6.61) 3.44%	(-0.11) 9.99%	(-0.31) 10.13%	(-2.41) 10.42%	(0.11) 12.82%	(0.71) 12.68%	(-0.11) 12.02%	(0.01) 12.10%
DIIs	(0.51) 21.00%	(7.11) 20.52%	(-1.11) 13.47%	(-0.41) 14.54%	(0.31) 14.97%	(-0.11) 14.68%	(-0.11) 14.79%	(0.01) 14.89%	(1.01) 14.88%	(0.61) 13.89%	(-0.11) 13.33%	(5.01) 13.46%	(-0.21) 8.45%	(-0.51) 8.68%	(2.01) 9.14%	(0.31) 7.15%	(0.21) 6.88%	(0.11) 6.71%	(0.01) 6.59%
Public	12.71%	13.61%	10.61%	11.18%	11.57%	11.49%	12.15%	11.49%	11.11%	11.64%	12.08%	11.95%	10.40%	10.04%	9.29%	8.85%	9.26%	10.09%	10.09%
No. of Shareholders	73,377	77,619	54,142	54,566	57,403	56,666	59,377	61,636	64,823	68,844	72,000	76,292	74,386	75,822	71,412	66,431	66,315	65,769	62,936

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	224	196	217	193	187	166	177	157	154	135	148	135	136	128	135	128	131	117	176	165
Sales Growth % (YoY)	19.7%	17.8%	22.1%	23%	21.3%	23.1%	19.8%	16.3%	13.5%	5.2%	9.6%	5.6%	4.1%	9%	-23.4%	-22.4%	-11.1%	-15.1%	15%	192.6%
Sales Growth % (QoQ)	14.3%	-9.7%	12.4%	3.2%	12.7%	-6.2%	12.7%	1.9%	14.1%	-8.8%	9.6%	-0.7%	6.2%	-5.2%	5.5%	-2.3%	12%	-33.5%	6.7%	-
Expenses	149	138	145	135	130	124	129	115	121	103	110	100	111	100	103	92	93	81	87	94
Operating Profit	75	58	71	58	57	42	48	42	34	32	38	35	25	28	32	36	38	37	89	71
OPM %	34	30	33	30	30	25	27	27	22	23	25	26	18	22	23	28	29	31	51	43
Other Income	5	-1	3	5	5	4	3	4	3	3	3	1	4	3	2	1	3	1	15	10
Interest	2	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	0	1	1
Depreciation	14	22	12	11	14	17	13	11	13	13	11	10	11	10	9	9	10	9	8	7
Profit before tax	64	35	63	50	47	28	37	34	23	20	28	25	17	20	24	28	30	29	95	74
Tax %	24	21	24	24	54	32	28	29	25	26	28	31	28	25	35	22	29	25	19	24
Net Profit	49	28	48	38	22	19	26	24	17	15	20	17	12	15	15	22	21	22	78	56
Net Profit Growth % (QoQ)	75%	-41.7%	26.3%	72.7%	15.8%	-26.9%	8.3%	41.2%	13.3%	-25%	17.6%	41.7%	-20%	-	-31.8%	4.8%	-4.5%	-71.8%	39.3%	-
Net Profit Growth % (YoY)	122.7%	47.4%	84.6%	58.3%	29.4%	26.7%	30%	41.2%	41.7%	-	33.3%	-22.7%	-42.9%	-31.8%	-80.8%	-60.7%	-	-	-	-
TTM Net Profit	163	136	127	105	91	86	82	76	69	64	64	59	64	73	80	143	177	156	134	0
EPS in Rs	2.96	1.82	3.02	2.45	1.36	1.2	1.68	1.52	1.12	0.97	1.28	1.09	0.79	0.93	0.97	4.11	4.01	4.06	14.7	10.51

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Sales	829	687	572	527	589	495	434	403	356	304	241	183
Sales Growth %	20.6%	20.2%	8.6%	-10.6%	19%	13.9%	7.8%	13.1%	17.1%	26.3%	31.7%	-
Expenses	566	498	432	403	353	323	261	249	212	189	147	110
Operating Profit	263	190	140	123	236	171	174	154	145	115	94	73
OPM %	32	28	24	23	40	35	40	38	41	38	39	40
Other Income	12	15	9	9	29	12	1	11	21	-15	7	8
Interest	4	4	6	5	3	1	2	1	0	0	1	0
Depreciation	59	55	47	39	34	30	32	26	20	18	18	13
Profit before tax	213	145	96	89	228	152	140	138	145	82	82	68
Tax %	24	38	28	27	23	26	37	38	36	48	37	35
Net Profit	163	91	69	64	176	113	88	85	93	43	52	44
Net Profit Growth %	79.1%	31.9%	7.8%	-63.6%	55.8%	28.4%	3.5%	-8.6%	116.3%	-17.3%	18.2%	-
EPS in Rs	10.24	5.76	4.45	4.06	11.1	7.13	5.58	5.38	5.79	2.66	3.21	2.98
Dividend Payout %	137	122	135	148	45	117	30	124	58	125	104	171

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Cash from Operating Activity	213	180	168	129	113	115	168	100	107	90	68	34
Cash from Investing Activity	-23	-41	-91	-39	-24	-49	1	-12	-43	-42	-18	-18
Cash from Financing Activity	-170	-130	-85	-86	-89	-62	-165	-94	-64	-49	-45	-23
Net Cash Flow	21	8	-8	4	0	4	4	-5	0	0	5	-6

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Equity Capital	159	53	53	53	53	53	53	53	53	53	54	54	54	51
Reserves	426	481	494	435	474	481	474	374	314	382	390	354	312	226
Borrowings	51	25	25	19	42	23	21	8	12	2	0	0	0	0
Other Liabilities	111	121	121	90	75	74	60	106	90	37	36	30	44	53
Total Liabilities	747	680	693	597	644	632	607	541	469	475	479	438	410	329
Fixed Assets	317	301	297	295	306	294	285	253	269	294	299	259	259	196
CWIP	3	3	14	1	3	2	3	8	5	1	0	17	1	6
Investments	177	146	162	108	162	144	146	126	90	95	120	104	93	86
Other Assets	250	230	220	193	173	192	173	154	105	84	60	58	56	42
Total Assets	747	680	693	597	644	632	607	541	469	475	479	438	410	329

Delivery

Delivery Data: THYROCARE

#	Date	506 31% 662	Value (Cr)	Q/T 43	Del 38	Del 87
1	4-Sep	576	8	8	55	4
2	3-Sep	579	11	8	61	7
3	2-Sep	577	20	17	51	10
4	1-Sep	591	15	18	55	8
5	31-Aug	604	39	25	68	26
6	28-Aug	584	10	14	50	5
7	27-Aug	581	23	18	53	12
8	26-Aug	605	13	25	55	7
9	25-Aug	596	16	16	38	6
10	24-Aug	584	22	21	50	11
11	21-Aug	566	19	17	53	10
12	20-Aug	567	39	20	62	24
13	19-Aug	582	32	26	50	16
14	18-Aug	608	17	16	45	8
15	17-Aug	619	19	17	46	9
16	14-Aug	624	78	44	68	54
17	13-Aug	606	409	78	41	169
18	12-Aug	643	75	13	50	37
19	11-Aug	649	39	18	46	18
20	10-Aug	622	21	22	52	11
21	7-Aug	603	13	16	46	6
22	6-Aug	598	11	19	44	5
23	5-Aug	600	36	39	68	24
24	4-Aug	605	63	25	56	35
25	3-Aug	593	38	29	56	21
26	31-Jul	579	17	21	56	10
27	30-Jul	591	38	27	43	16
28	29-Jul	580	22	32	46	10
29	28-Jul	580	39	29	31	12
30	27-Jul	584	236	37	29	67
31	24-Jul	564	693	44	8	55
32	23-Jul	545	17	12	47	8
33	22-Jul	558	21	13	36	8
34	21-Jul	563	36	22	61	22
35	20-Jul	556	66	23	34	22
36	17-Jul	521	12	16	53	6
37	16-Jul	527	17	16	47	8
38	15-Jul	530	18	17	46	8
39	14-Jul	540	40	28	25	10
40	13-Jul	510	23	16	61	14
41	10-Jul	516	22	17	55	12
42	9-Jul	536	10	13	52	5
43	8-Jul	522	18	17	52	9
44	7-Jul	532	14	17	59	9
45	6-Jul	545	13	14	51	7
46	3-Jul	556	13	20	41	5
47	2-Jul	557	10	18	54	5
48	1-Jul	543	13	14	53	7
49	30-Jun	549	25	27	50	13
50	29-Jun	524	18	21	43	8

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	9,197c	2c	0.03
03-Sep	9,199c	202c	2.15
01-Sep	9,401c	47c	0.50
31-Aug	9,448c	159c	1.71
27-Aug	9,289c	319c	3.32
26-Aug	9,608c	217c	2.31
25-Aug	9,391c	96c	1.03
24-Aug	9,295c	274c	3.03
21-Aug	9,022c	210c	2.28
19-Aug	9,232c	478c	4.92
18-Aug	9,709c	159c	1.61
17-Aug	9,868c	78c	0.78
14-Aug	9,946c	174c	1.78
13-Aug	9,772c	447c	4.37
12-Aug	10,218c	293c	2.95
11-Aug	9,926c	0	0
10-Aug	9,926c	484c	5.12
06-Aug	9,442c	136c	1.42
04-Aug	9,578c	378c	4.11
31-Jul	9,200c	285c	3.00
30-Jul	9,485c	250c	2.71
29-Jul	9,235c	35c	0.38
28-Jul	9,200c	64c	0.69
27-Jul	9,263c	267c	2.96
24-Jul	8,997c	0	0

Stock Checklist

Price is above from 52 week high low average: 74%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 64 fund scheme(s) across 14 fund house(s) as of Aug26 · Total value ₹3,500 Cr · 34 increasing / 14 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Nippon India Mutual Fund	4	0.60%	+0.23%	1063.6
ICICI Prudential Mutual Fund	12	1.02%	-0.10%	887.6
HSBC Mutual Fund	4	1.68%	+0.35%	707.6
Aditya Birla Sun Life Mutual Fund	10	1.37%	+0.64%	554.4
HDFC Mutual Fund	4	1.40%	-0.06%	165.5
Bank of India Mutual Fund	2	0.83%	+0.82%	46.3
WhiteOak Capital Mutual Fund	2	2.21%	+0.04%	31.1
Motilal Oswal Mutual Fund	4	0.39%	+0.09%	19.1
Shriram Mutual Fund	6	1.80%	+0.40%	12.7
Samco Mutual Fund	2	2.29%	-	6
Bandhan Mutual Fund	6	0.56%	+0.53%	4.5
Groww Mutual Fund	4	0.21%	+1.10%	1.9
Angel One Mutual Fund	2	0.02%	+0.01%	0
Mirae Asset Mutual Fund	2	0.02%	+0.01%	0

Thyrocare Technologies Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements